Paper23744404
Lack of reduction of left ventricular mass in treated hypertension: the strong heart study.
de Simone G and 6 others. J Am Heart Assoc, 2013. Cited by 73 papers, by iCite.
Cite this record
ConductScience Library. Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. Papers, record 23744404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23744404
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lack of reduction of left ventricular mass in treated hypertension: the strong heart study.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Hypertension | Major topic |
| Hypertrophy, Left Ventricular | Major topic |
| Aged | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Longitudinal Studies | |
| Male | |
| Middle Aged |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HL65521 | NHLBI NIH HHS | United States | U01HL065521 | PubMed and NIH | NIH RePORTER |
| U01 HL041642 | NHLBI NIH HHS | United States | U01HL041642 | PubMed and NIH | NIH RePORTER |
| M01 RR000047 | NCRR NIH HHS | United States | M01RR000047 | PubMed and NIH | NIH RePORTER |
| U01 HL065521 | NHLBI NIH HHS | United States | U01HL065521 | PubMed and NIH | NIH RePORTER |
| HL41652 | NHLBI NIH HHS | United States | U01HL041652 | PubMed and NIH | NIH RePORTER |
| U01 HL041654 | NHLBI NIH HHS | United States | U01HL041654 | PubMed and NIH | NIH RePORTER |
| U01 HL041652 | NHLBI NIH HHS | United States | U01HL041652 | PubMed and NIH | NIH RePORTER |
| M10RR0047-34 | NCRR NIH HHS | United States | M10RR004734 | PubMed | NIH RePORTER |
| HL41642 | NHLBI NIH HHS | United States | U01HL041642 | PubMed and NIH | NIH RePORTER |
| HL41654 | NHLBI NIH HHS | United States | U01HL041654 | PubMed and NIH | NIH RePORTER |
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2698218 | Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. | J Am Soc Echocardiogr | 1989 | https://conductscience.org/library/papers/2698218 | PubMed |
| 2 | 11057435 | Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. | J Hypertens | 2000 | https://conductscience.org/library/papers/11057435 | PubMed |
| 3 | 9040574 | Blood-pressure control in the hypertensive population. | Lancet | 1997 | https://conductscience.org/library/papers/9040574 | PubMed |
| 4 | 8712120 | Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). | Am J Cardiol | 1996 | https://conductscience.org/library/papers/8712120 | PubMed |
| 5 | 1401629 | Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. | J Am Coll Cardiol | 1992 | https://conductscience.org/library/papers/1401629 | PubMed |
| 6 | 19361968 | Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study. | Nutr Metab Cardiovasc Dis | 2009 | https://conductscience.org/library/papers/19361968 | PubMed |
| 7 | 19502281 | Identifying needs and opportunities for advancing translational research in cardiovascular disease. | Cardiovasc Res | 2009 | https://conductscience.org/library/papers/19502281 | PubMed |
| 8 | 19231334 | Temporal obesity trends in patients undergoing transthoracic echocardiography 2002-2006. | Am J Cardiol | 2009 | https://conductscience.org/library/papers/19231334 | PubMed |
| 9 | 15323062 | Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. | Am J Hypertens | 2004 | https://conductscience.org/library/papers/15323062 | PubMed |
| 10 | 23032140 | Determinants of blood pressure treatment and control in obese people: evidence from the general population. | J Hypertens | 2012 | https://conductscience.org/library/papers/23032140 | PubMed |
| 11 | 21775111 | Impact of overweight and obesity on cardiac benefit of antihypertensive treatment. | Nutr Metab Cardiovasc Dis | 2013 | https://conductscience.org/library/papers/21775111 | PubMed |
| 12 | 16208150 | Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. | J Hypertens | 2005 | https://conductscience.org/library/papers/16208150 | PubMed |
| 13 | 18794402 | Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. | Circulation | 2008 | https://conductscience.org/library/papers/18794402 | PubMed |
| 14 | 15326072 | Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. | Circulation | 2004 | https://conductscience.org/library/papers/15326072 | PubMed |
| 15 | 2936235 | Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. | Am J Cardiol | 1986 | https://conductscience.org/library/papers/2936235 | PubMed |
| 16 | 22573071 | Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. | J Hypertens | 2012 | https://conductscience.org/library/papers/22573071 | PubMed |
| 17 | 11403367 | Regression of left ventricular hypertrophy in human hypertension with irbesartan. | J Hypertens | 2001 | https://conductscience.org/library/papers/11403367 | PubMed |
| 18 | 23032141 | Prognostic value of the extent of left ventricular hypertrophy and its evolution in the hypertensive patient. | J Hypertens | 2012 | https://conductscience.org/library/papers/23032141 | PubMed |
| 19 | 2136980 | Does increased blood pressure cause left ventricular hypertrophy or vice versa? | Ann Intern Med | 1990 | https://conductscience.org/library/papers/2136980 | PubMed |
| 20 | 14678345 | Differences between clinical trials and postmarketing use. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/14678345 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39296817 | The Pandora's Box of Hypertensive Heart Disease in Women. | JACC Adv | 2024 | https://conductscience.org/library/papers/39296817 | PubMed |
| 38963706 | The use of echocardiography compared to electrocardiogram when screening for left ventricular hypertrophy in hypertensive patients: A cross-sectional study. | J Clin Hypertens (Greenwich) | 2024 | https://conductscience.org/library/papers/38963706 | PubMed |
| 38946010 | Electrocardiographic tracking of left ventricular hypertrophy in hypertension: incidence and prognostic outcomes from the SPRINT trial. | Clin Hypertens | 2024 | https://conductscience.org/library/papers/38946010 | PubMed |
| 38571722 | The cardiovascular changes underlying a low cardiac output with exercise in patients with type 2 diabetes mellitus. | Front Physiol | 2024 | https://conductscience.org/library/papers/38571722 | PubMed |
| 38238511 | Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension. | Hypertens Res | 2024 | https://conductscience.org/library/papers/38238511 | PubMed |
| 38205639 | Phosphate in Cardiovascular Disease: From New Insights Into Molecular Mechanisms to Clinical Implications. | Arterioscler Thromb Vasc Biol | 2024 | https://conductscience.org/library/papers/38205639 | PubMed |
| 37794691 | Influence of hypertension and global or abdominal obesity on left ventricular hypertrophy: A cross-sectional study. | J Clin Hypertens (Greenwich) | 2024 | https://conductscience.org/library/papers/37794691 | PubMed |
| 37342440 | Hypertensive heart disease: risk factors, complications and mechanisms. | Front Cardiovasc Med | 2023 | https://conductscience.org/library/papers/37342440 | PubMed |
| 36917110 | Association of High Normal Body Weight in Youths With Risk of Hypertension. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/36917110 | PubMed |
| 36606285 | Prognostic implication of left ventricular hypertrophy regression after antihypertensive therapy in patients with hypertension. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36606285 | PubMed |
| 36136303 | Sex differences in arterial hypertension. | Eur Heart J | 2022 | https://conductscience.org/library/papers/36136303 | PubMed |
| 36082119 | Sex differences in hypertension. Do we need a sex-specific guideline? | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36082119 | PubMed |
| 36030347 | Sex, gender, and subclinical hypertensiveorgan damage-heart. | J Hum Hypertens | 2023 | https://conductscience.org/library/papers/36030347 | PubMed |
| 35788967 | Cardiovascular Disease Risk Reduction and Body Mass Index. | Curr Hypertens Rep | 2022 | https://conductscience.org/library/papers/35788967 | PubMed |
| 35043688 | Carotid Atherosclerosis Predicts Blood Pressure Control in Patients With Hypertension: The Campania Salute Network Registry. | J Am Heart Assoc | 2022 | https://conductscience.org/library/papers/35043688 | PubMed |
| 35032013 | High incidence of hypertension-mediated organ damage in a series of Chinese patients with 17α-hydroxylase deficiency. | Endocrine | 2022 | https://conductscience.org/library/papers/35032013 | PubMed |
| 34733358 | Hypertension in Women: Should There be a Sex-specific Threshold? | Eur Cardiol | 2021 | https://conductscience.org/library/papers/34733358 | PubMed |
| 34426850 | Left Ventricular Measurements and Strain in Pediatric Patients Evaluated for Systemic Hypertension and the Effect of Adequate Anti-hypertensive Treatment. | Pediatr Cardiol | 2022 | https://conductscience.org/library/papers/34426850 | PubMed |
| 34081212 | Prognostic Significance of Echocardiographic Measures of Cardiac Remodeling in the Community. | Curr Cardiol Rep | 2021 | https://conductscience.org/library/papers/34081212 | PubMed |
| 32889649 | A Contemporary Approach to Hypertensive Cardiomyopathy: Reversing Left Ventricular Hypertrophy. | Curr Hypertens Rep | 2020 | https://conductscience.org/library/papers/32889649 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE | 1636 | PubTator's text mining | https://conductscience.org/library/genes/1636 | NCBI Gene |
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| AP2B1 | 163 | PubTator's text mining | https://conductscience.org/library/genes/163 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23744404
GET https://conductscience.org/api/papers/v1/23744404/references?page=2